GPHB5 Is a Biomarker in Women With Metabolic Syndrome: Results From Cross-Sectional and Intervention Studies.

Front Endocrinol (Lausanne) · 2022 · PMC9218212 · PMID 35757403

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

At the beginning of EHC, elevated insulin levels led to a slight increase in GPHB5 concentration, but did not reach statistical significance (from 2.86 ± 1.21 μg/L at 80 min to 3.2 ± 1.26 μg/L at 100 min and then to 3.16 ± 1.34 μg/L at 120 min; Figure 4H ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.